Navigation Links
AACR annual meeting showcases developments in understanding and targeting cancers
Date:4/8/2008

SAN DIEGO -- Cutting-edge breakthroughs in molecular targeting, translational cancer research and cancer prevention will take center stage when more than 17,000 scientists from around the world gather at the San Diego Convention Center April 12-16 for the 2008 Annual Meeting of the American Association for Cancer Research (AACR). Key data presented at the meeting will include late-breaking clinical trial findings related to high-profile, potentially life-saving cancer therapies in the pipeline.

"Cancer research is now a vast multidisciplinary field encompassing nearly all areas of science and technology. This is truly an extraordinary time," said William N. Hait, M.D., Ph.D., president of the AACR and senior vice president for Worldwide Hematology and Oncology Research and Development at Johnson & Johnson. "Today, basic cancer research drives cancer medicine and it is increasingly influenced by clinical observations. Clearly, these synergies are advancing our knowledge about cancer for the benefit of cancer patients, and the AACR is the catalyst for these discoveries."

The theme of the 2008 Annual Meeting is "Translating the Latest Discoveries into Cancer Prevention and Cures," and the opening plenary will feature insight and perspective from world leaders in cancer research on topics ranging from the cellular mechanisms of metastasis, to cancer prevention, to targeted drug therapies and clinical trials.

AACR's Annual Meeting attracts attendees including leading academic, industry and government scientists, as well as clinical oncologists, students, cancer survivors, advocates and other health care professionals. Such a diverse group facilitates a cross-disciplinary exchange of new ideas and collaborations. This year, more than 6,000 abstracts were selected for presentation, complementing an outstanding program of scientific and educational events.

Late-breaking plenary sessions in basic, translational and clinical cancer research will cover the latest advances from the laboratory and their translational potential to the clinic. Special sessions will also feature phase I and phase II studies of novel therapeutic agents in early stage clinical trials, as well as late-breaking phase III clinical trial data.

"We are in an exciting phase of cancer research. Collectively, we have built upon years of scientific advances and have accelerated the process of moving cancer research from basic to translational to clinical science, and back," said Eileen P. White, Ph.D., chairperson of the 2008 Program Committee and associate director for basic science at Rutgers University. "With advanced diagnostic technologies and new drugs and therapies we are saving more lives, extending the lives of cancer patients, and improving their quality of life."

To better communicate important science to the public, the AACR has selected nearly 50 abstracts for presentation by their authors in nine press briefings, each highlighting a critical or emerging area of cancer research. Featured press briefing topics include:

  • How personalized medicine is changing the cancer treatment landscape
  • New cancer drugs from early safety and efficacy studies to late-breaking phase III clinical trials
  • How diet and lifestyle choices may affect one's risk of cancer
  • The science of cancer health disparities among racial and ethnic minorities.

Additional briefings will focus on the latest research in cancer prevention, prognosis, diagnosis, immunotherapy and late-breaking clinical trials.

With the aim of inspiring the next generation of young cancer researchers, the AACR has invited nearly 300 local high school students from ten high schools to participate in "The Conquest of Cancer and the Next Generation," a day-long program on the floor of the AACR meeting that will feature educational lectures, a tour of poster displays and exhibits, and a networking reception. Many of these high school students will be paired with mentors among the AACR membership for guidance and education.


'/>"/>

Contact: Staci Vernick Goldberg
Staci.goldberg@aacr.org
267-646-0616
American Association for Cancer Research
Source:Eurekalert

Related biology news :

1. Planetary geoscience, paleontology, and more at GSA Annual Meeting in Denver next month
2. CIC Again Named to Software Magazines Annual Prestigious Software 500 List
3. Colony collapse disorder symposium added to ESA Annual Meeting
4. Food and environmental sustainability focus of ASA-CSSA-SSSA Annual Meetings
5. Canadian Society of Exercise Physiology Annual Scientific Conference
6. Fourth Annual International Conference on Cell Therapy for Cardiovascular Diseases
7. New studies on schizophrenia, depression, trauma and autism highlight annual meeting
8. Oceanographer Dennis J. McGillicuddy, Jr. receives 34th annual Rosenstiel Award
9. Cell biologists announce child-care grants for scientist-parents at annual meeting
10. 5th annual Keys bonefish population census results announced
11. 5th Annual World Health Care Congress April 21-23, Washington, D.C.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... , Apr. 11, 2017 Research and ... Market 2017-2021" report to their offering. ... The global eye tracking market to grow at a ... report, Global Eye Tracking Market 2017-2021, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
(Date:4/5/2017)... April 5, 2017 Today HYPR Corp. ... the server component of the HYPR platform is officially ... the end-to-end security architecture that empowers biometric authentication across ... has already secured over 15 million users across the ... of connected home product suites and physical access represent ...
(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University (PolyU) ... ground breaking 3D fingerprint minutiae recovery and matching technology, pushing contactless ... use in identification, crime investigation, immigration control, security of access and ... ... A research team led by Dr Ajay Kumar ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017  SkylineDx ... London (ICR) and University of Leeds ... to risk-stratify patients with multiple myeloma (MM), in a multi-centric ... The University of Leeds is the ... UK, and ICR will perform the testing services to include ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today announced ... to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B ... to cross the cell membrane and bind intracellular STAT3 and inhibit its function. ...
(Date:10/10/2017)... Philadelphia, PA (PRWEB) , ... October 10, 2017 ... ... University City Science Center’s FirstHand program has won a US2020 STEM Mentoring Award. ... accept the award for Excellence in Volunteer Experience from US2020. , US2020’s mission ...
(Date:10/10/2017)... , Oct. 10, 2017 SomaGenics announced ... the NIH to develop RealSeq®-SC (Single Cell), expected to ... profiling small RNAs (including microRNAs) from single cells using ... highlights the need to accelerate development of approaches to ... "New techniques for measuring levels of ...
Breaking Biology Technology: